Indoco Remedies Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Key Metrics
PE ratio
-
PB ratio
1.61
Dividend yield
0.10%
Beta
0.31
Market cap
₹18.31B
Enterprise value
₹28.21B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 6000 |
| Website | https://www.indoco.com |
| Mailing address | Indoco House 166 CST Road Santacruz (East) Kalina Mumbai 400098 India |
| Phone / Fax | 91 22 6287 1000 / 91 22 6287 1050 |
Dividends
Dividend yield
0.10%
Dividend amount
₹0.20
Payout ratio
45.39%
5Y Avg. yield
-%
Indoco Remedies Limited paid ₹0.20 dividend and the ex-dividend date was 04 Sep 2025.The dividend payout ratio is 45.39%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.INDOCO dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Indoco Remedies Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Suresh Govind Kare | Non-Executive Chairman & Whole time Director | 86 | |
| Mr. Sundeep Vasant Bambolkar | Joint MD & Executive Director | 65 | |
| Ms. Aditi Milind Panandikar | MD & Executive Director | 55 | |
| Mr. Pramod Ghorpade | Chief Financial Officer | ||
| Mr. Ramanathan N. Hariharan | Head of Legal, Company Secretary & Compliance Officer | ||
| Mr. Dileep Mahajan | Vice President of Operations | ||
| Dr. Kavita Inamdar | Chief Technical Officer | 58 | |
| Mr. Ajay Karajagi | President of Sales & Marketing | ||
| Mr. Rajesh Usgaonker | Chief Marketing Officer | ||
| Mr. Rajan B Saawant | Vice President of Corporate HR |
Profitability and management effectiveness
Profit margin
-6.47%
Operating margin
-0.11%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Indoco Remedies Limited is 18.31B and its enterprise value is 28.21B. The enterprise value to revenue ratio of INDOCO is 1.60. The enterprise value to EBITDA ratio of INDOCO is 28.65.
The INDOCO's stocks Beta value is 0.31 making it 69% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Indoco Remedies Limited (NSE:INDOCO) Frequently Asked Questions
1. What is Indoco Remedies Limited's Stock Symbol?
Indoco Remedies Limited trades on NSE under the ticker symbol "INDOCO".
2. What is Indoco Remedies Limited's stock price today?
One share of INDOCO stock can currently be purchased for approximately ₹198.36.
3. How can I contact Indoco Remedies Limited?
Indoco Remedies Limited's mailing address is Indoco House 166 CST Road Santacruz (East) Kalina Mumbai 400098 India. The company can be reached via phone at 91 22 6287 1000.
4. What is Indoco Remedies Limited's official website?
The official website of Indoco Remedies Limited is https://www.indoco.com.